yohimbine derivatives (University of Tennessee/University of Mississippi/University of Tennessee Research Foundation Office of Technology Transfer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameyohimbine derivatives (University of Tennessee/University of Mississippi/University of Tennessee Research Foundation Office of Technology Transfer)
Drug Alias Nameadrenergic receptor alpha 2c antagonists (University of Tennessee/University of Mississippi/University of Tennessee Research Foundation Office of Technology Transfer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor antagonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsRaynaud Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Tennessee Research Foundation Office of Technology TransferThe University Of TennesseeUniversity Of Mississippi
Active IndicationsN/A
Inactive IndicationsRaynaud Disease

Other Information

ATC CodeN/A
Related LinksN/A